Repeat-Dose Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers.

Trial Profile

Repeat-Dose Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers.

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 13 Oct 2017

At a glance

  • Drugs Cytisine (Primary)
  • Indications Smoking withdrawal
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Achieve Life Sciences
  • Most Recent Events

    • 04 Oct 2017 According to an Achieve Life Sciences media release, the company has initiated this trial to support a pivotal Phase 3 trial in the United States (see profile 700287776). This study is expected to be completed by the end of the year, with data expected by the first-quarter of 2018.
    • 04 Oct 2017 Status changed from not yet recruiting to recruiting, as reported in an Achieve Life Sciences media release.
    • 17 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top